IL-10: The master regulator of immunity to infection

Journal of Immunology

Volumn 180, Issue 9, 2008, Pages 5771-5777

  Couper, Kevin N ^a   Blount, Daniel G ^a,b   Riley, Eleanor M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

DENDRITIC CELL; IMMUNOPATHOLOGY; INFECTION; MACROPHAGE; NATURAL KILLER CELL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TISSUE INJURY; ANIMAL; ANTIBODY SPECIFICITY; BACTERIAL INFECTION; HUMAN; IMMUNOLOGY; PATHOLOGY; PROTOZOAL INFECTION; VIRUS INFECTION;

ANIMALS; BACTERIAL INFECTIONS; HUMANS; INTERLEUKIN-10; KILLER CELLS, NATURAL; MACROPHAGES; ORGAN SPECIFICITY; PROTOZOAN INFECTIONS; TH1 CELLS; VIRUS DISEASES;

EID: 44449096726     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.9.5771     Document Type: Review

References (96)

1. + T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J. Immunol. 157: 798-805.
2. Hunter, C. A., L. A. Ellis-Neyes, T. Slifer, S. Kanaly, G. Grunig, M. Fort, D. Rennick, and F. G. Araujo. 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158: 3311-3316. (Pubitemid 127484048)
3. Li, C., I. Corraliza, and J. Langhorne. 1999. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect. Immun. 67: 4435-4442. (Pubitemid 29400417)
4. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170: 2081-2095.
5. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683-765. (Pubitemid 32368050)
6. Kamanaka, M., S. T. Kim, Y. Y. Wan, F. S. Sutterwala, M. Lara-Tejero, J. E. Galán, E. Harhaj, and R. A. Flavell. 2006. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25: 941-952.
7. Demangel, C., P. Bertolino, and W. J. Britton. 2002. Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur. J. Immunol. 32: 994-1002. (Pubitemid 34428814)
8. Schandene, L., C. Alonso-Vega, F. Willems, C. Gerard, A. Delvaux, T. Velu, R. Devos, M. de Boer, and M. Goldman. 1994. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol. 152: 4368-4374. (Pubitemid 24134394)
9. Joss, A., M. Akdis, A. Faith, K. Blaser, and C. A. Akdis. 2000. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur. J. Immunol. 30: 1683-1690. (Pubitemid 30342811)
10. Wilson, E. H., U. Wille-Reece, F. Dzierszinski, and C. A. Hunter. 2005. A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol. 165: 63-74. (Pubitemid 40984624)
11. Magez, S., B. Stijlemans, G. Caljon, H. P. Eugster, and P. De Baetselier. 2002. Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-α induction. Infect. Immun. 70: 1342-1351. (Pubitemid 34163410)
12. Grau, G. E., L. F. Fajardo, P. F. Piguet, B. Allet, P. H. Lambert, and P. Vassalli. 1987. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237: 1210-1212. (Pubitemid 17124914)
13. Rudin, W., N. Favre, G. Bordmann, and B. Ryffel. 1997. Interferon-γ is essential for the development of cerebral malaria. Eur. J. Immunol. 27: 810-815. (Pubitemid 27153646)
14. Bekker, L. G., G. Maartens, L. Steyn, and G. Kaplan. 1998. Selective increase in plasma tumor necrosis factor-α and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis. J. Infect. Dis. 178: 580-584. (Pubitemid 28347951)
15. + regulatory T cells control the severity of viral immunoinflammatory lesions. J. Immunol. 172: 4123-4132.
16. Li, C., L. A. Sanni, F. Omer, E. Riley, and J. Langhorne. 2003. Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10- deficient mice are ameliorated by anti-tumor necrosis factor α and exacerbated by anti-transforming growth factor β antibodies. Infect. Immun. 71: 4850-4856. (Pubitemid 37070725)
17. - adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog. In press.
18. Grunig, G., D. B. Corry, M. W. Leach, B. W. Seymour, V. P. Kurup, and D. M. Rennick. 1997. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J. Exp. Med. 185: 1089-1099. (Pubitemid 27136801)
19. Wilson, M. S., E. Elnekave, M. M. Mentink-Kane, M. G. Hodges, J. T. Pesce, T. R. Ramalingam, R. W. Thompson, M. Kamanaka, R. A. Flavell, A. Keane-Myers, et al. 2007. IL-13Rα2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J. Clin. Invest. 117: 2941-2951. (Pubitemid 47529624)
20. Hoffmann, K. F., A. W. Cheever, and T. A. Wynn. 2000. IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J. Immunol. 164: 6406-6416. (Pubitemid 30408823)
21. H2 paradigm. Nat. Rev. Immunol. 4: 583-594.
22. Nelson, D. R., G. Y. Lauwers, J. Y. Lau, and G. L. Davis. 2000. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology 118: 655-660. (Pubitemid 30171614)
23. Hernandez-Pando, R., D. Aguilar, M. L. Hernandez, H. Orozco, and G. Rook. 2004. Pulmonary tuberculosis in BALB/c mice with non-functional IL-4 genes: changes in the inflammatory effects of TNF-α and in the regulation of fibrosis. Eur. J. Immunol. 34: 174-183. (Pubitemid 38111533)
24. Wohlleben, G., C. Trujillo, J. Muller, Y. Ritze, S. Grunewald, U. Tatsch, and K. J. Erb. 2004. Helminth infection modulates the development of allergen-induced airway inflammation. Int. Immunol. 16: 585-596. (Pubitemid 38489433)
25. Omer, F. M., J. B. de Souza, and E. M. Riley. 2003. Differential induction of TGF-β regulates proinflammatory cytokine production and determines the outcome of lethal and nonlethal Plasmodium yoelii infections. J. Immunol. 171: 5430-5436. (Pubitemid 37432830)
26. + regulatory T cell responses during the early stages of infection in susceptible and resistant mice. Exp. Parasitol. 115: 301-304.
27. Anderson, C. F., S. Mendez, and D. L. Sacks. 2005. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice. J. Immunol. 174: 2934-2941. (Pubitemid 40279712)
28. Belkaid, Y., K. F. Hoffmann, S. Mendez, S. Kamhawi, M. C. Udey, T. A. Wynn, and D. L. Sacks. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194: 1497-1506. (Pubitemid 33081524)
29. Murphy, M. L., U. Wille, E. N. Villegas, C. A. Hunter, and J. P. Farrell. 2001. IL-10 mediates susceptibility to Leishmania donovani infection. Eur. J. Immunol. 31: 2848-2856. (Pubitemid 32994535)
30. Reed, S. G., C. E. Brownell, D. M. Russo, J. S. Silva, K. H. Grabstein, and P. J. Morrissey. 1994. IL-10 mediates susceptibility to Trypanosoma cruzi infection. J. Immunol. 153: 3135-3140. (Pubitemid 24292538)
31. Roque, S., C. Nobrega, R. Appelberg, and M. Correia-Neves. 2007. IL-10 underlies distinct susceptibility of BALB/c and C57BL/6 mice to Mycobacterium avium infection and influences efficacy of antibiotic therapy. J. Immunol. 178: 8028-8035. (Pubitemid 46898074)
32. Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. Oldstone. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12: 1301-1309.
33. Ejrnaes, M., C. M. Filippi, M. M. Martinic, E. M. Ling, L. M. Togher, S. Crotty, and M. G. von Herrath. 2006. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203: 2461-2472. (Pubitemid 44664616)
34. Hesse, M., C. A. Piccirillo, Y. Belkaid, J. Prufer, M. Mentink-Kane, M. Leusink, A. W. Cheever, E. M. Shevach, and T. A. Wynn. 2004. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J. Immunol. 172: 3157-3166. (Pubitemid 38263706)
35. Groux, H., F. Cottrez, M. Rouleau, S. Mauze, S. Antonenko, S. Hurst, T. McNeil, M. Bigler, M. G. Roncarolo, and R. L. Coffman. 1999. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol. 162: 1723-1729. (Pubitemid 29307051)
36. Feng, C. G., M. C. Kullberg, D. Jankovic, A. W. Cheever, P. Caspar, R. L. Coffman, and A. Sher. 2002. Transgenic mice expressing human interleukin-10 in the antigen-presenting cell compartment show increased susceptibility to infection with Mycobacterium avium associated with decreased macrophage effector function and apoptosis. Infect. Immun. 70: 6672-6679. (Pubitemid 35387897)
37. - Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204: 285-297.
38. Karp, C. L., S. H. el-Safi, T. A. Wynn, M. M. Satti, A. M. Kordofani, F. A. Hashim, M. Hag-Ali, F. A. Neva, T. B. Nutman, and D. L. Sacks. 1993. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-γ. J. Clin. Invest. 91: 1644-1648.
39. Kapsenberg, M. L. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3: 984-993. (Pubitemid 37521540)
40. Mills, K. H. 2004. Regulatory T cells: friend or foe in immunity to infection? Nat. Rev. Immunol. 4: 841-855. (Pubitemid 39490760)
41. Boonstra, A., R. Rajsbaum, M. Holman, R. Marques, C. Asselin-Paturel, J. P. Pereira, E. E. Bates, S. Akira, P. Vieira, Y. J. Liu, et al. 2006. Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J. Immunol. 177: 7551-7558.
42. Fujita, S., K. Seino, K. Sato, Y. Sato, K. Eizumi, N. Yamashita, M. Taniguchi, and K. Sato. 2006. Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. Blood 107: 3656-3664.
43. Han, X., S. Wang, Y. Fan, J. Yang, L. Jiao, H. Qiu, and X. Yang. 2006. Chlamydia infection induces ICOS ligand-expressing and IL-10-producing dendritic cells that can inhibit airway inflammation and mucus overproduction elicited by allergen challenge in BALB/c mice. J. Immunol. 176: 5232-5239.
44. Higgins, S. C., E. C. Lavelle, C. McCann, B. Keogh, E. McNeela, P. Byrne, B. O'Gorman, A. Jarnicki, P. McGuirk, and K. H. Mills. 2003. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol. 171: 3119-3127. (Pubitemid 37093535)
45. van der Kleij, D., E. Latz, J. F. Brouwers, Y. C. Kruize, M. Schmitz, E. A. Kurt-Jones, T. Espevik, E. C. de Jong, M. L. Kapsenberg, D. T. Golenbock, et al. 2002. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates Toll-like receptor 2 and affects immune polarization. J. Biol. Chem. 277: 48122-48129. (Pubitemid 35470760)
46. Jang, S., S. Uematsu, S. Akira, and P. Salgame. 2004. IL-6 and IL-10 induction from dendritic cells in response to Mycobacterium tuberculosis is predominantly dependent on TLR2-mediated recognition. J. Immunol. 173: 3392-3397. (Pubitemid 39142049)
47. Perry, J. A., C. S. Olver, R. C. Burnett, and A. C. Avery. 2005. Cutting Edge: the acquisition of TLR tolerance during malaria infection impacts T cell activation. J. Immunol. 174: 5921-5925. (Pubitemid 40663776)
48. Sponaas, A. M., E. T. Cadman, C. Voisine, V. Harrison, A. Boonstra, A. O'Garra, and J. Langhorne. 2006. Malaria infection changes the ability of splenic dendritic cell populations to stimulate antigen-specific T cells. J. Exp. Med. 203: 1427-1433. (Pubitemid 43877605)
49. Yanagawa, Y., and K. Onoe. 2007. Enhanced IL-10 production by TLR4- and TLR2-primed dendritic cells upon TLR restimulation. J. Immunol. 178: 6173-6180. (Pubitemid 46717399)
50. + T cell response. J. Immunol. 178: 5429-5433.
51. Edwards, J. P., X. Zhang, K. A. Frauwirth, and D. M. Mosser. 2006. Biochemical and functional characterization of three activated macrophage populations. J. Leukocyte Biol. 80: 1298-1307.
52. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166: 1141-1147. (Pubitemid 32060273)
53. Netea, M. G., R. Sutmuller, C. Hermann, C. A. Van der Graaf, J. W. Van der Meer, J. H. van Krieken, T. Hartung, G. Adema, and B. J. Kullberg. 2004. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172: 3712-3718. (Pubitemid 38337955)
54. Sing, A., D. Rost, N. Tvardovskaia, A. Roggenkamp, A. Wiedemann, C. J. Kirschning, M. Aepfelbacher, and J. Heesemann. 2002. Yersinia V-antigen exploits Toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. 196: 1017-1024. (Pubitemid 35231760)
55. Katakura, T., M. Miyazaki, M. Kobayashi, D. N. Herndon, and F. Suzuki. 2004. CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J. Immunol. 172: 1407-1413. (Pubitemid 38116782)
56. Balcewicz-Sablinska, M. K., H. Gan, and H. G. Remold. 1999. Interleukin 10 produced by macrophages inoculated with Mycobacterium avium attenuates mycobacteria-induced apoptosis by reduction of TNF-α activity. J. Infect. Dis. 180: 1230-1237. (Pubitemid 30070208)
57. Butcher, B. A., L. Kim, A. D. Panopoulos, S. S. Watowich, P. J. Murray, and E. Y. Denkers. 2005. IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-α in host macrophages. J. Immunol. 174: 3148-3152. (Pubitemid 40354013)
58. + T cells for IL-2 and exploit it for the induction of IL-10 production. Int. Immunol. 17: 279-288.
59. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201: 723-735.
60. Wan, Y. Y., and R. A. Flavell. 2007. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445: 766-770. (Pubitemid 46279706)
61. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352.
62. Belkaid, Y. 2007. Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 7: 875-888. (Pubitemid 350006238)
63. + T regulatory cells suppress Helicobacter hepaticus-induced colitis. J. Exp. Med. 196: 505-515.
64. + regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
65. Shevach, E. M. 2006. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25: 195-201. (Pubitemid 44224153)
66. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
67. Chen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237-1240. (Pubitemid 24291983)
68. - Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204: 273-283.
69. - precursor cells in the absence of interleukin 10. Nat. Immunol. 8: 931-941.
70. Stumhofer, J. S., J. S. Silver, A. Laurence, P. M. Porrett, T. H. Harris, L. A. Turka, M. Ernst, C. J. Saris, J. J. O'Shea, and C. A. Hunter. 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8: 1363-1371. (Pubitemid 350131173)
71. Fitzgerald, D. C., G. X. Zhang, M. El-Behi, Z. Fonseca-Kelly, H. Li, S. Yu, C. J. Saris, B. Gran, B. Ciric, and A. Rostami. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8: 1372-1379. (Pubitemid 350131174)
72. Awasthi, A., Y. Carrier, J. P. Peron, E. Bettelli, M. Kamanaka, R. A. Flavell, V. K. Kuchroo, M. Oukka, and H. L. Weiner. 2007. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8: 1380-1389. (Pubitemid 350131175)
73. McGeachy, M. J., K. S. Bak-Jensen, Y. Chen, C. M. Tato, W. Blumenschein, T. McClanahan, and D. J. Cua. 2007. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat. Immunol. 8: 1390-1397. (Pubitemid 350138974)
74. Gerosa, F., C. Paganin, D. Peritt, F. Paiola, M. T. Scupoli, M. Aste-Amezaga, I. Frank, and G. Trinchieri. 1996. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-γ and interleukin-10. J. Exp. Med. 183: 2559-2569. (Pubitemid 26192366)
75. Vanden Eijnden, S., S. Goriely, D. De Wit, F. Willems, and M. Goldman. 2005. IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human. Eur. J. Immunol. 35: 469-475. (Pubitemid 40331324)
76. Meyaard, L., E. Hovenkamp, S. A. Otto, and F. Miedema. 1996. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J. Immunol. 156: 2776-2782. (Pubitemid 126660624)
77. McGuirk, P., C. McCann, and K. H. Mills. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195: 221-231. (Pubitemid 34461266)
78. + T cells by streptococcal M protein. J. Immunol. 175: 677-684.
79. Roers, A., L. Siewe, E. Strittmatter, M. Deckert, D. Schluter, W. Stenzel, A. D. Gruber, T. Krieg, K. Rajewsky, and W. Muller. 2004. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. 200: 1289-1297. (Pubitemid 39552570)
80. + T cells in vivo. J. Immunol. 167: 4534-4542.
81. + (Foxp3) regulatory T cells in human visceral leishmaniasis. J. Exp. Med. 204: 805-817.
82. Keller, C. C., O. Yamo, C. Ouma, J. M. Ong'echa, D. Ounah, J. B. Hittner, J. M. Vulule, and D. J. Perkins. 2006. Acquisition of hemozoin by monocytes downregulates interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-10-dependent mechanism: in vivo and in vitro findings in severe malarial anemia. Infect. Immun. 74: 5249-5260.
83. Kossodo, S., C. Monso, P. Juillard, T. Velu, M. Goldman, and G. E. Grau. 1997. Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology 91: 536-540. (Pubitemid 27312334)
84. Holscher, C., M. Mohrs, W. J. Dai, G. Kohler, B. Ryffel, G. A. Schaub, H. Mossmann, and F. Brombacher. 2000. Tumor necrosis factor α-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect. Immun. 68: 4075-4083. (Pubitemid 30434562)
85. Madura Larsen, J., C. Stabell Benn, Y. Fillie, D. van der Kleij, P. Aaby, and M. Yazdanbakhsh. 2007. BCG stimulated dendritic cells induce an interleukin-10 producing T-cell population with no T helper 1 or T helper 2 bias in vitro. Immunology 121: 276-282. (Pubitemid 46663096)
86. Fleming, S. D., P. J. Leenen, J. H. Freed, and P. A. Campbell. 1999. Surface interleukin-10 inhibits listericidal activity by primary macrophages. J. Leukocyte Biol. 66: 961-967. (Pubitemid 30010521)
87. Ross, P. J., E. C. Lavelle, K. H. Mills, and A. P. Boyd. 2004. Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells. Infect. Immun. 72: 1568-1579. (Pubitemid 38263779)
88. Sadler, C. H., L. I. Rutitzky, M. J. Stadecker, and R. A. Wilson. 2003. IL-10 is crucial for the transition from acute to chronic disease state during infection of mice with Schistosoma mansoni. Eur. J. Immunol. 33: 880-888. (Pubitemid 36546675)
89. Chen, C. C., S. Louie, B. A. McCormick, W. A. Walker, and H. N. Shi. 2006. Helminth-primed dendritic cells alter the host response to enteric bacterial infection. J. Immunol. 176: 472-483. (Pubitemid 43023293)
90. Segura, M., Z. Su, C. Piccirillo, and M. M. Stevenson. 2007. Impairment of dendritic cell function by excretory-secretory products: a potential mechanism for nematode-induced immunosuppression. Eur. J. Immunol. 37: 1887-1904. (Pubitemid 47065127)
91. Ji, J., G. K. Sahu, V. L. Braciale, and M. W. Cloyd. 2005. HIV-1 induces IL-10 production in human monocytes via a CD4-independent pathway. Int. Immunol. 17: 729-736. (Pubitemid 41417971)
92. + T cells. J. Immunol. 178: 3265-3271.
93. Brady, M. T., A. J. MacDonald, A. G. Rowan, and K. H. Mills. 2003. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur. J. Immunol. 33: 3448-3457. (Pubitemid 37541123)
94. Humphreys, I. R., C. de Trez, A. Kinkade, C. A. Benedict, M. Croft, and C. F. Ware. 2007. Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands. J. Exp. Med. 204: 1217-1225. (Pubitemid 46798163)
95. Redpath, S., A. Angulo, N. R. Gascoigne, and P. Ghazal. 1999. Murine cytomegalo-virus infection down-regulatesMHCclass II expression on macrophages by induction of IL-10. J. Immunol. 162: 6701-6707. (Pubitemid 29309395)
96. + regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. 169: 6298-6308.